Delivery Order SPE2DB20D2104-SPE2DB25FMWYU
Award Date 7/31/25
Potential Completion Date 8/1/25
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $3,364.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on August 22, 2025, with an ultimate completion date of August 25, 2025. The delivery order covers Myfembree 40 mg–1 mg–0.5 mg tablets in a 28-day supply, a hormonal contraceptive medication. This is a non-set-aside competitive award issued against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- This delivery order, valued at $3,159.63, represents a competitively awarded, non-set-aside contract issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Myfembree (a combination oral contraceptive containing 40 mg, 1 mg, and 0.5 mg tablets in a 28-count package). The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and reflects the firm fixed pricing structure typical of DLA pharmaceutical procurement. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,220.88 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Myfembree (elagolix/estradiol/norethindrone acetate) tablets in multiple dosage strengths (40 mg, 1 mg, and 0.5 mg formulations) in a 28-tablet package. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, with performance to be completed by August 14, 2025, and fulfillment occurring at the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.46 to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets in a 28-count package). This firm fixed-price, non-set-aside contract was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,002.97, is a delivery order with a firm fixed price. It covers the provision of MYFEMBREE 40 MG-1 MG-0.5 MG tablets, with an ultimate completion date of November 8, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.79 firm fixed-price delivery order contract, with a completion date of January 8, 2025, is for the supply of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,547.13, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 8, 2025. There is no set-aside designation for this contract. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,345.59, is for the delivery of MYFEMBREE 40 MG-1 MG-0.5 MG tablets. It is a firm fixed-price delivery order contract that runs through April 1, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,295.88 firm fixed-price delivery order contract is for the pharmaceutical product MYFEMBREE 40 MG-1 MG-0.5 MG TB 28S, with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,530.93 delivery order contract is for the provision of Myfembree, a branded pharmaceutical product, on a firm fixed price basis. The contract has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...